Terms: = Sarcomas AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck AND Treatment
2 results:
1. The SH3 domain of p56lck is involved in binding to phosphatidylinositol 3'-kinase from T lymphocytes.
Vogel LB; Fujita DJ
Mol Cell Biol; 1993 Dec; 13(12):7408-17. PubMed ID: 7504174
[TBL] [Abstract] [Full Text] [Related]
2. Preclinical antitumor activity of orally administered platinum (IV) complexes.
Rose WC; Crosswell AR; Schurig JE; Casazza AM
Cancer Chemother Pharmacol; 1993; 32(3):197-203. PubMed ID: 8500224
[TBL] [Abstract] [Full Text] [Related]
